Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine With or Without Integration Therapy for TRD
NCT07369102Phase 4Recruiting
- Sponsor
- University of Puerto Rico
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in treatment-resistant depression (TRD), sponsored by University of Puerto Rico. Started Feb 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07369102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369102.